8 articles with Cardiac Insight
Cardiac Insight, Inc. Partners with VivoSense® (Vivonoetics, Inc.) to Expand the Use of Its Wearable Cardiac Sensors in Regulated Pharmaceutical Clinical Trials and Other Healthcare Research Applications
Partnership to Provide Advanced Insights Into Performance of New Medicines and Therapies
Cardiac Insight’s Wearable ECG Sensor, Cardea SOLO™, Continues to Attract Premier Cardiology Groups Across the U.S.; Announces Baltimore Heart Associates and Regional Cardiac Arrhythmia as Customers
Company Experiencing Steady Sales Growth and Strong Repeat Orders from Existing Customers
Cardiac Insight, Inc. to Showcase Industry-First Cardiac Devices for Atrial Fibrillation and Sudden Cardiac Arrest Risk Detection at Heart Rhythm 2018, Heart Rhythm Society’s 39th Annual Scientific Sessions, May 9-11, Exhibit 1071
Cardiac Insight, Inc. announced the company will showcase its innovative solutions for the first time at Heart Rhythm Society’s 39th Annual Scientific Sessions.
Early physician and patient experiences with Cardea SOLO are confirming the FDA-cleared cardiac device, designed to streamline arrhythmia detection in patients, is providing a higher standard of ambulatory cardiac care and efficiencies in cardiac practices.
Cardiac Insight Continues Steady Beat Of Progress With New $4.5 Million Investment And Attracts Prestigious Healthcare M&A Executive, Clifford J. Stocks, To Its Board Of Directors
Cardiac Insight’s "Cardea SOLO" Supports Top Arrhythmia Experts’ Acknowledgement: Wearable Cardiac Monitors Are Effective For Tracking Atrial Fibrillation Following Cardiac Ablation
Cardiac Insight Acquires Cardea Associates To Bring Forth New Standard Of Care For Cardiac Screening In Young Athletes